Literature DB >> 33509087

Higher genome variability within metabolism genes associates with recurrent Clostridium difficile infection.

Maria Kulecka1,2, Edyta Waker3, Filip Ambrozkiewicz1, Agnieszka Paziewska1,2, Karolina Skubisz2, Patrycja Cybula2, Łukasz Targoński4, Michał Mikula1, Jan Walewski4, Jerzy Ostrowski5,6.   

Abstract

BACKGROUND: Clostridium difficile (C. difficile) is a major source of healthcare-associated infection with a high risk of recurrence, attributable to many factors such as usage of antibiotics, older age and immunocompromised status of the patients. C. difficile has also a highly diverse genome, which may contribute to its high virulence. Herein we examined whether the genome conservation, measured as non-synonymous to synonymous mutations ratio (dN/dS) in core genes, presence of single genes, plasmids and prophages increased the risk of reinfection in a subset of 134 C. difficile isolates from our previous study in a singly hemato-oncology ward.
METHODS: C. difficile isolates were subjected to whole-genome sequencing (WGS) on Ion Torrent PGM sequencer. Genomes were assembled with MIRA5 and annotated with prokka and VRprofile. Logistic regression was used to asses the relationship between single gene presence and the odds of infection recurrence. DN/dS ratios were computed with codeml. Functional annotation was conducted with eggNOG-Mapper.
RESULTS: We have found that the presence of certain genes, associated with carbon metabolism and oxidative phosphorylation, increased the odds of infection recurrence. More core genes were under positive selective pressure in recurrent disease isolates - they were mostly associated with the metabolism of aminoacids. Finally, prophage elements were more prevalent in single infection isolates and plasmids did not influence the odds of recurrence.
CONCLUSIONS: Our findings suggest higher genetic plasticity in isolates causing recurrent infection, associated mainly with metabolism. On the other hand, the presence of prophages seems to reduce the isolates' virulence.

Entities:  

Keywords:  Clostridium difficile; Infection; Prophage; Recurrence; Whole genome sequencing

Year:  2021        PMID: 33509087      PMCID: PMC7842062          DOI: 10.1186/s12866-021-02090-9

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


  83 in total

1.  European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.

Authors:  S B Debast; M P Bauer; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2014-03       Impact factor: 8.067

Review 2.  An Update on Clostridium difficile Toxinotyping.

Authors:  Maja Rupnik; Sandra Janezic
Journal:  J Clin Microbiol       Date:  2015-10-28       Impact factor: 5.948

Review 3.  Diagnosis and treatment of Clostridium difficile in adults: a systematic review.

Authors:  Natasha Bagdasarian; Krishna Rao; Preeti N Malani
Journal:  JAMA       Date:  2015-01-27       Impact factor: 56.272

4.  Effect of phage infection on toxin production by Clostridium difficile.

Authors:  Shan Goh; Barbara J Chang; Thomas V Riley
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

5.  Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention.

Authors:  Sara Lynn Revolinski; L Silvia Munoz-Price
Journal:  Clin Infect Dis       Date:  2019-05-30       Impact factor: 9.079

6.  Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938.

Authors:  Paul A Lawson; Diane M Citron; Kerin L Tyrrell; Sydney M Finegold
Journal:  Anaerobe       Date:  2016-06-28       Impact factor: 3.331

7.  Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.

Authors:  Glen P Carter; Anjana Chakravorty; Tu Anh Pham Nguyen; Steven Mileto; Fernanda Schreiber; Lucy Li; Pauline Howarth; Simon Clare; Bliss Cunningham; Susan P Sambol; Adam Cheknis; Iris Figueroa; Stuart Johnson; Dale Gerding; Julian I Rood; Gordon Dougan; Trevor D Lawley; Dena Lyras
Journal:  MBio       Date:  2015-06-02       Impact factor: 7.867

8.  Deciphering Adaptation Strategies of the Epidemic Clostridium difficile 027 Strain during Infection through In Vivo Transcriptional Analysis.

Authors:  Imad Kansau; Amira Barketi-Klai; Marc Monot; Sandra Hoys; Bruno Dupuy; Claire Janoir; Anne Collignon
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

Review 9.  Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention.

Authors:  Jung Hoon Song; You Sun Kim
Journal:  Gut Liver       Date:  2019-01-15       Impact factor: 4.519

Review 10.  Clostridium difficile infection: a review of current and emerging therapies.

Authors:  Andrew Ofosu
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun
View more
  2 in total

Review 1.  Computational approaches to understanding Clostridioides difficile metabolism and virulence.

Authors:  Matthew L Jenior; Jason A Papin
Journal:  Curr Opin Microbiol       Date:  2021-11-25       Impact factor: 7.934

2.  Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study.

Authors:  Masoumeh Azimirad; YoungJae Jo; Min-Sueng Kim; Minsoo Jeong; Shabnam Shahrokh; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali; Seungjun Lee; Abbas Yadegar; Jae-Ho Shin
Journal:  J Inflamm Res       Date:  2022-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.